期刊文献+

同型半胱氨酸对乳腺癌患者外周血单个核细胞uPA系统表达的影响

Effect of homocysteine on peripheral mononuclear cell expressing uPA system in patients with breast carcinoma
下载PDF
导出
摘要 目的:探讨Hcy是否影响乳腺癌患者外周血MNC表达uPA、uPAR和PAI-1.方法:采用不同浓度Hcy对乳腺癌患者外周血MNC进行短期(4h)培养后,粉碎细胞,ELISA法检测其uPA,uPAR和PAI-1的表达.结果:Hcy诱导乳腺癌患者外周血MNC表达uPA,uPAR,而抑制MNC表达PAI-1,并且呈剂量依赖性,Hcy浓度为0,12.5,25,50,100μmol/L时,uPA分别为47.00±21.26,57.70±26.72,72.38±38.64,83.33±42.74,94.83±44.47 ng/L;uPAR分别为1299.3±291.7,1447.2±408.8,1607.6±467.0,1731.3±521.1,1815.3±522.3 ng/L;PAI-1分别为52.5±20.7,41.6±21.9,35.4±17.9,32.6±18.3,28.7±16.2μg/L.结论:Hcy可以影响乳腺癌患者外周血MNC表达uPA,uPAR和PAI-1,可能在乳腺癌的侵袭和转移中发挥一定的作用. AIM: To explore whether homocysteine affects the peripheral mononuclear cells (MNC) in expressing urokinase-type plasminogen activator (uPA) , urokinase-type plasminogen active receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) in patients with breast carcinoma. METHODS: The peripheral MNCs were incubated with euhure liquids of different Hcy concen- trations for 4 h and then were smashed, and the levels of uPA, uPAR and PAI-1 were measured by ELISA. RESULTS: Hcy induced the expression of uPA and uPAR but inhibited the expression PAI-1 in a dose-dependent manner. CONCLUSION: Hcy affects the peripheral mononuelear cells in expressing uPA, uPAR and PAI-1, and may play a role in the invasion and metastasis of the breast carcinoma.
出处 《第四军医大学学报》 北大核心 2009年第14期1339-1341,共3页 Journal of the Fourth Military Medical University
基金 宁夏自然科学基金(NZ0064)
关键词 高半胱氨酸 单核细胞 尿纤溶酶原激活物 尿纤溶酶原激活物受体 纤溶酶原激活物抑制物 乳腺肿瘤 homocysteine monocytes urinary plasminogen acti-vator urokinase-type plasminogen active receptor plasminogen activator inhibitor-1 breast neoplasms
  • 相关文献

参考文献16

  • 1Jiang X,Zhu S,Panetti TS,et al.Formation of tissue factor-factor Ⅶa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells[J].Thromb Haemost,2008,100(1):127-133.
  • 2Jiang X,Guo YL,Bromberg ME.Formation of tissue factor-factor Ⅶa-factor Xa complex prevents apoptosis in human breast cancer colls[J].Thremb Haemost,2006,96(2):196-201.
  • 3Annecke K,Schmitt M,Euler U,et al.uPA and PAI-1 in breast cancer:review of their clinical utility and current validation in the prospective NNBC-3 trial[J].Adv Clin Chem,2008,45:31-45.
  • 4Subramanian R,Gondi CS,Lakka SS,et al.siRNA-mediated simulteneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells[J].Int J Oncol,2006,28(4):831-839.
  • 5Ziegler RG,Weinstein SJ,Fears TR.Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk[J].J Nutr,2002,132:2345S-2349S.
  • 6王亚萍,肖锦华,顾筱敏,李月珍.消化系恶性肿瘤患者血浆Hcy水平检测及临床分析[J].放射免疫学杂志,2005,18(5):368-369. 被引量:5
  • 7乔蕊,张捷,汪整辉,梁国成,吴永华.7种肿瘤患者血浆同型半胱氨酸水平的初步探讨[J].现代检验医学杂志,2006,21(5):7-10. 被引量:16
  • 8Sun CF,Haven TR,Wu TL,et al.Serum total homocysteine in creases with the rapid proliferation rate of tumor cells and decline upon cell death:a potential new tumor marker[J].Clin Chim Acta,2002,321:55-62.
  • 9Swiercz R,Keck RW,Skrzypesak-Jankun E,et al.Recombinant PM-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice[J].Oncol Rep,2001,8(3):463-470.
  • 10Prans M,Wauterickx K,Collen D,et al.Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors[J].Gene,1999,6(2):227.

二级参考文献35

  • 1武文心,朱广瑾,段岩平.实验性心肌梗塞大鼠冠脉等组织纤溶因子表达的变化[J].基础医学与临床,1997,17(1):29-33. 被引量:3
  • 2Hajjar K A. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor [J]. J Clin Investig, 1993, 91:2873-2879.
  • 3Ling Q, Hajjar K A. Inhibition of endothelial cell thromboresistance by homocysteine[J]. J Nutrg, 2000, 130:373S-376S.
  • 4Saed G M, Diamond M P. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypo xia in human peritoneal and adhesion fibroblasts[J ]. Fertility stertility, 2003, 79(1) :164-168.
  • 5Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophagederived tissue factor activity in rats[J]. FASEBJ, 1997,11:1157-1168.
  • 6Tofler G H, D' Agostino R B, Jacques P F, et al. Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk [J ]. Thromb Haemost, 2002, 88: 799-804.
  • 7Lindgren A, Lindoff C, Norrving B. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients[J]. Stroke, 1996, 27:1066-1071.
  • 8Midorikawa S, Sanada H, Hashimoto S, et al. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells[J]. Biochem Biophys Res Commun, 2000, 272:182-185.
  • 9Hansen NQ, Aras O, Yang F, et al. C677 T and A1289 C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and postmethionine load homocysteine in vascular disease. Clinical Chemistry. 2001, 47:661.
  • 10Me Quillan BM, Beilby JP, Nidorf M, et al. Hyperhomocysteinemia but not the C667T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. Circulation. 1999,99:2383.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部